Raptor Pharmaceuticals Corp. (RPTP)
Raptor Pharmaceuticals Corp. is a development stage biotechnology company. The company engages in the discovery, research, and preclinical development of drug candidates and drug-targeting platforms for the treatment of various brain disorders and neurodegenerative diseases, genetic disorders, and cancer through the proprietary use of receptor-associated proteins and mesoderm development proteins. Raptor Pharmaceuticals Corp was founded in 2005 and is based in Novato, California.
| ||||
Total Income, Quarterly
Profit margin
Net income
Revenue / Net income
Short Term
Long Term
Accounts payable| 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 |
|---|---|---|---|
| 35M | 3096000 | 3923000 | 3463000 |
Chart
Short current long term debt| 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 |
|---|---|---|---|
| 3000 | 4000 | 4000 | 4000 |
Chart
Other current liabilities| 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 |
|---|---|---|---|
| 27000 | 24M | 25M | 27M |
Chart
Cash and cash equivalents| 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 |
|---|---|---|---|
| 13M | 15M | 25M | 20M |
Chart
Short term investments| 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 |
|---|---|---|---|
| - | - | 30M | 30M |
Chart
Other current assets| 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 |
|---|---|---|---|
| 191000 | 416000 | 330000 | 2340000 |
Chart
Long term debt| 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 |
|---|---|---|---|
| - | 10000 | 9000 | 8000 |
Chart
Property plant and equipment| 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 |
|---|---|---|---|
| 65000 | 77000 | 71000 | 223000 |
Chart
Intangible assets| 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 |
|---|---|---|---|
| 3397000 | 3251000 | 3214000 | 3178000 |
Chart
Other assets| 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 | 31 Dec, 69 |
|---|---|---|---|
| 105000 | 105000 | 105000 | 105000 |
Chart
Short Term
Long Term
To see the headquarters in Google Street View &trade, drag this yellow guy: 
over to the red pointer: 
Contact Information:
| Business Address: | - |
| Mailing Address: | 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949 Business Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949 415-382-1390 Raptor Ph |
| Phone: | 415-382-8111 |
| Fax: | 415-382-1368 |
| Website: | http://www.raptorpharma.com |
Company Details:
| Symbol: | RPTP |
| SIC: | - |
| State location: | CA |
| Sector: | - |
| State of Inc: | DE |
| Employees: | 12 |
| Type: | NASDAQ |
Key executives:
| Name | Age | Position |
|---|---|---|
| Christopher M. Starr Ph.D. | 59 | Co founder, Chief Exec. Officer, Pres, Director, Chief Exec. Officer of Raptor Pharmaceutical Inc of Raptor Pharmaceutical Inc |
| Guojun Bu Ph.d | - | Member of Medical and Scientific Advisory Board - Raptor Pharmaceutical Inc |
| Kim R. Tsuchimoto | - | Chief Financial Officer, Principal Accounting Officer, Sec., Treasurer, Chief Financial Officer of Raptor Pharmaceutical Inc., Sec. of Raptor Pharmaceutical Inc. and Treasurer of Raptor Pharmaceutical Inc |
| Rivka Sherman-Gold Ph.D. | - | Member of Medical and Scientific Advisory Board of Raptor Pharmaceutical Inc |
| Todd C. Zankel Ph.D. | 48 | Chief Scientific Officer and Chief Scientific Officer of Raptor Pharmaceutical Inc |
Raptor Pharmaceutical Corp. (NASDAQ:RPTP) Confirms the Sideways Moves Aug 16, 2010
As the news about the private placement was confirmed through the corresponding 8-k filing on Friday, the trend of Raptor Pharmaceutical Corp. (NASDAQ:RPTP) shares getting oversold finally reversed.read more
| Post # | Subject | Re | Name | Date |
|---|---|---|---|---|
| 1 | Most probably the company does not have... | 0 | Paul Andrew | February 01, 2008, 03:52AM |
| 2 | Here on this message board we are inviting... | 0 | Guest | February 01, 2008, 03:52AM |